Literature DB >> 21600530

Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Paul N Hopkins1, Peter P Toth, Christie M Ballantyne, Daniel J Rader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21600530     DOI： 10.1016/j.jacl.2011.03.452

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN： 1876-4789            Impact factor:   4.766


× No keyword cloud information.
  68 in total

Review 1.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

Authors:  Lora E Burke; Jun Ma; Kristen M J Azar; Gary G Bennett; Eric D Peterson; Yaguang Zheng; William Riley; Janna Stephens; Svati H Shah; Brian Suffoletto; Tanya N Turan; Bonnie Spring; Julia Steinberger; Charlene C Quinn
Journal:  Circulation       Date:  2015-08-13       Impact factor: 29.690

2.  Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.

Authors:  Maya S Safarova; Eric W Klee; Linnea M Baudhuin; Erin M Winkler; Michelle L Kluge; Suzette J Bielinski; Janet E Olson; Iftikhar J Kullo
Journal:  Eur J Hum Genet       Date:  2017-02-01       Impact factor: 4.246

3.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Authors:  Amanda M Perak; Hongyan Ning; Sarah D de Ferranti; Holly C Gooding; John T Wilkins; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 4.  Familial hypercholesterolemia.

Authors:  Victoria Enchia Bouhairie; Anne Carol Goldberg
Journal:  Cardiol Clin       Date:  2015-05       Impact factor: 2.213

5.  Reducing the burden of disease and death from familial hypercholesterolemia: a call to action.

Authors:  Joshua W Knowles; Emily C O'Brien; Karen Greendale; Katherine Wilemon; Jacques Genest; Laurence S Sperling; William A Neal; Daniel J Rader; Muin J Khoury
Journal:  Am Heart J       Date:  2014-09-16       Impact factor: 4.749

Review 6.  The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia.

Authors:  Yashashwi Pokharel; Salim S Virani; Christie M Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

7.  Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

Authors:  Leonardo De Luca; Marcello Arca; Pier L Temporelli; Furio Colivicchi; Lucio Gonzini; Donata Lucci; Biagio Bosco; Mariella Callerame; Giulio V Lettica; Andrea Di Lenarda; Michele M Gulizia
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

8.  Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.

Authors:  Sarah J Hardcastle; Ellen Legge; Chris S Laundy; Sarah J Egan; Rosemary French; Gerald F Watts; Martin S Hagger
Journal:  Int J Behav Med       Date:  2015-02

9.  Genealogical analysis as a new approach for the investigation of drug intolerance heritability.

Authors:  Marc Tremblay; Tarek Bouhali; Daniel Gaudet; Diane Brisson
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

10.  Predicting Self-Management Behaviors in Familial Hypercholesterolemia Using an Integrated Theoretical Model: the Impact of Beliefs About Illnesses and Beliefs About Behaviors.

Authors:  Martin S Hagger; Sarah J Hardcastle; Catherine Hingley; Ella Strickland; Jing Pang; Gerald F Watts
Journal:  Int J Behav Med       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.